Last reviewed · How we verify

NCT06988631

Sensorimotor Organization in Individuals With General Joint Hypermobility

Completed NA Last updated 25 May 2025
What this trial tests

NA trial testing Sensory treatment in Generalized Joint Hypermobility in 65 participants. Completed in 15 December 2024.

Timeline
15 January 2024
Primary endpoint
15 November 2024
15 December 2024

Quick facts

Lead sponsorGazi University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment65
Start date15 January 2024
Primary completion15 November 2024
Estimated completion15 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

Adults 18 to 25, any sex, with Generalized Joint Hypermobility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is the first to examine the effect of sole sensory training on sensorimotor organization in individuals with GEH. Individuals with a Beighton score of 5 and above were included in the study. Within the scope of the study, individuals with general joint hypermobility (GEH) were divided into intervention and control groups by the Randomization method. The intervention group received sole sensory training in the home environment. Both groups were given a foot care brochure. The individuals' sole sensory and balance skills were evaluated before and after the intervention. As a result of the study, the intervention aimed to prevent injuries and disabilities that may occur due to joint laxity by improving sole sensory and balance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06988631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing